CIPO Patents = 1

EPO Patents = 1

Forward Citations = 0

Loading Chart...

10 inventors (with patents filed for the assignee):

Didier Schils (4 out of 7 patents)

Ludivine Zoute (4 out of 7 patents)

Julien Parcq (4 out of 8 patents)

4. Hamid R Hoveyda (4 out of 51 patents)

5. Guillaume Dutheuil (2 out of 2 patents)

6. Graeme Lovat Fraser (1 out of 38 patents)

7. François Lenoir (1 out of 1 patent)

8. Julien Korac (1 out of 1 patent)

9. Killian Oukoloff (1 out of 1 patent)

10. Catherine Sorlet (1 out of 1 patent)

11. Michel Detheux (14 patents)

12. Vincent Lannoy (4 patents)

13. Jerome Bernard (0 patent)

14. Marc Parmentier (0 patent)

6 patents: Sort by Forward Citations

1. 12091400 - Piperidine derivatives as METTL3 inhibitors (2024-09-17),

2. 12054457 - Polymorphs of (2S,5R)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereof (2024-08-06),

3. 11072582 - Substituted pyrrolidines as G-protein coupled receptor 43 agonists (2021-07-27),

4. 10781171 - Substituted pyrrolidines as G-protein coupled receptor 43 agonists (2020-09-22),

5. 10577318 - Substituted pyrrolidines as G-protein coupled receptor 43 agonists (2020-03-03),

6. 10358416 - Substituted pyrrolidines as G-protein coupled receptor 43 agonists (2019-07-23),

Epics Therapeutics is a biotechnology company focused on developing novel therapies for cancer and autoimmune diseases. With a team of experienced scientists and cutting-edge technology, Epics Therapeutics is dedicated to advancing the field of precision medicine to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

6 Patents

#5 in Charleroi

#381 in Belgium

Charleroi, Belgium

Epics Therapeutics

Forward Citations = 0

10 inventors:

Didier Schils (4 out of 7 patents)

Ludivine Zoute (4 out of 7 patents)

Julien Parcq (4 out of 8 patents)

4. Hamid R Hoveyda (4 out of 51 patents)

5. Guillaume Dutheuil (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com